RE: [NMusers] analysis of non-positive DV

2011-09-21 Thread Xiao, Alan
...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] On Behalf Of Vinogradova Svetlana Sent: Wednesday, September 21, 2011 8:26 AM To: nmusers@globomaxnm.com Subject: [NMusers] analysis of non-positive DV Dear NONMEM users, I'm analyzing a dataset of 4 patients, there are 2 types of observa

RE: [NMusers] analysis of non-positive DV

2011-09-21 Thread Ken Kowalski
Subject: [NMusers] analysis of non-positive DV Dear NONMEM users, I'm analyzing a dataset of 4 patients, there are 2 types of observations for each patient - vehicle (say baseline) and dose (treatment). We want to analyze our dataset in terms of (treatment-baseline). So I've modified my da

Re: [NMusers] analysis of non-positive DV

2011-09-21 Thread Leonid Gibiansky
Svetlana, The answer depends on whether you would like to allow your effect to be negative or not. If yes, you need to rewrite the model so that the model allows negative predictions, for example, EFF = TBAS + TSLP*CP**TALP where TSLP is allowed to be negative. If not, then you can use the

RE: [NMusers] analysis of non-positive DV

2011-09-21 Thread Bill Bachman
: Wednesday, September 21, 2011 8:26 AM To: nmusers@globomaxnm.com Subject: [NMusers] analysis of non-positive DV Dear NONMEM users, I'm analyzing a dataset of 4 patients, there are 2 types of observations for each patient - vehicle (say baseline) and dose (treatment). We want to analyze our da

Re: [NMusers] analysis of non-positive DV

2011-09-21 Thread Sebastien Bihorel
Have a look at those two references: J Pharmacokinet Pharmacodyn. 2009 Oct;36(5):381-405. Epub 2009 Aug 21. Methods of utilizing baseline values for indirect response models. Woo S, Pawaskar D, Jusko WJ. J Pharmacokinet Pharmacodyn. 2008 Jun;35(3):269-83. Epub 2008 Apr 30. Approaches to handli

[NMusers] analysis of non-positive DV

2011-09-21 Thread Vinogradova Svetlana
Dear NONMEM users, I'm analyzing a dataset of 4 patients, there are 2 types of observations for each patient - vehicle (say baseline) and dose (treatment). We want to analyze our dataset in terms of (treatment-baseline). So I've modified my dataset, and now I have only one "column" of observat